Skip to main content

Day: November 17, 2022

MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

ROCKVILLE, MD, Nov. 17, 2022 (GLOBE NEWSWIRE) —   MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today reported that the U.S. Food and Drug Administration announced the approval of the Biologics License Application (BLA) for teplizumab, an anti-CD3 monoclonal antibody that was previously developed by MacroGenics.  Teplizumab was acquired by Provention Bio, Inc. in May 2018 pursuant to an asset purchase agreement.  “We are very pleased to see the culmination of years of effort by Provention, MacroGenics, and tireless champions in academia and government, with the achievement of the approval of teplizumab,” said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. “We applaud this outcome, which represents...

Continue reading

Toll Brothers Apartment Living® Tops Out Broad & Noble, a New Luxury High-Rise Apartment Community Coming to Philadelphia

The 18-story, 344-unit luxury mixed-use apartment community totals more than 282k square feet and includes more than 10k square feet of ground-floor retail spaceBroad & Noble Topping-Out Celebration in Philadelphia, PA Philadelphia City Council member Mark Squilla joins members of the Broad & Noble development team, including Toll Brothers Apartment Living, Sundance Bay, and Clemens Construction Company, for a ceremonial beam-signing before the beam was hoisted to the top of the construction site.Broad & Noble Topping-Out Celebration in Philadelphia, PA Members of the Ironworkers Local Union 401 take part in a ceremonial beam-signing before the beam was hoisted to the top of the construction site.PHILADELPHIA, Nov. 17, 2022 (GLOBE NEWSWIRE) — Toll Brothers Apartment Living®, the rental subsidiary of Toll Brothers,...

Continue reading

ToughBuilt Industries Announces Closing of $7.5 Million Private Placement Priced At-The-Market under Nasdaq Rules

IRVINE, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced that it has closed its previously announced private placement with several institutional investors for the issuance and sale of 2,619,911 shares of common stock (or pre-funded warrants in lieu thereof) and preferred investment options to purchase up to 10,619,911 shares of common stock at an offering price of $2.862692 per share (or pre-funded warrant) and accompanying preferred investment options, priced at-the-market under Nasdaq rules. The preferred investment options are exercisable immediately upon issuance, have a term of three years and an exercise price of $2.356 per share. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds...

Continue reading

ToughBuilt Industries Announces $7.5 Million Private Placement Priced At-The-Market under Nasdaq Rules

LAKE FOREST, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced that it has entered into definitive agreements with several institutional investors for the issuance and sale of 2,619,911 shares of common stock (or pre-funded warrants in lieu thereof) and preferred investment options to purchase up to 10,619,911 shares of common stock at an offering price of $2.862692 per share (or pre-funded warrant) and accompanying preferred investment options, in a private placement priced at-the-market under Nasdaq rules. The preferred investment options are exercisable immediately upon issuance, have a term of three years and an exercise price of $2.356 per share. The private placement is expected to close on or about November 17, 2022, subject to the...

Continue reading

Transocean Acquires Interest in High Specification Ultra-Deepwater Newbuild Drillship

STEINHAUSEN, Switzerland, Nov. 17, 2022 (GLOBE NEWSWIRE) — Transocean Ltd. (“Transocean”) today announced that one of its subsidiaries, together with Perestroika A.S. and funds managed by Lime Rock Management L.P., have formed a joint venture, Liquila Ventures Ltd. (“Liquila Ventures”). Liquila Ventures agreed with Daewoo Shipbuilding & Marine Engineering Co., Ltd. (“DSME”), to purchase Hull 3623, the ultra-deepwater newbuild drillship formerly known as West Aquila, for approximately $200 million. Hull 3623 is a high specification, 1400 short-ton hookload ultra-deepwater drillship. This seventh-generation dual-activity drillship will have a large deck space, high load capacities, and will be dual-stack ready. Transocean has made a $15 million noncontrolling investment in Liquila Ventures and maintains the exclusive right to...

Continue reading

Goldstar Acquires Claims in Québec

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES MONTRÉAL, Nov. 17, 2022 (GLOBE NEWSWIRE) — Goldstar Minerals Inc. (“Goldstar” or the “Corporation”) (TSX-V: GDM) is pleased to announce that it has entered into a Purchase and Sale Agreement (the “Agreement”), effective October 27, 2022, with Jean Bernard (the “Owner”) with respect to a property (the “Property”), consisting of 2 claims and covering an area of approximately 120 hectares (1.2 km2). The Property is located in the Montérégie region of southern Québec. The Agreement provides for the acquisition of an undivided interest of 100% in the Property by paying the Owner $25,000 plus applicable taxes and issuing 500,000 common shares of the Corporation. Upon commercial production, Goldstar will issue an additional 1,000,000 common shares of the Corporation. Closing...

Continue reading

Post Holdings Reports Results for the Fourth Quarter and Fiscal Year 2022

ST. LOUIS, Nov. 17, 2022 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the fourth fiscal quarter and fiscal year ended September 30, 2022. Highlights:Fourth quarter net sales of $1.6 billion; operating profit of $131.9 million; net earnings from continuing operations of $83.9 million and Adjusted EBITDA of $279.7 million Fiscal year net sales of $5.9 billion; operating profit of $415.6 million; net earnings from continuing operations of $735.0 million and Adjusted EBITDA of $963.5 million Generated $384.2 million in cash from continuing operations in fiscal year 2022 Fiscal year 2023 Adjusted EBITDA (non-GAAP) expected to range between $990-$1,040 millionBasis of Presentation On March 10, 2022, Post’s distribution to its shareholders of 80.1% of its...

Continue reading

BellRing Brands Reports Results for the Fourth Quarter and Fiscal Year 2022

ST. LOUIS, Nov. 17, 2022 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global convenient nutrition category, today reported results for the fourth fiscal quarter and fiscal year ended September 30, 2022. Highlights:Fourth quarter net sales of $379.2 million, operating profit of $61.1 million; net earnings available to common stockholders of $33.7 million and Adjusted EBITDA of $79.9 million Fiscal year net sales of $1,371.5 million, operating profit of $212.4 million; net earnings available to common stockholders of $82.3 million and Adjusted EBITDA of $271.4 million Fiscal year 2023 net sales and Adjusted EBITDA expected to range between $1.56-$1.64 billion and $300-$325 million, respectivelyFourth Quarter Operating Results Net sales were $379.2 million, an increase of...

Continue reading

Acuity Brands Announces Upcoming Retirement of Dominic J. Pileggi and Ray M. Robinson from the Board of Directors

Atlanta, Nov. 17, 2022 (GLOBE NEWSWIRE) — The Board of Directors (the “Board”) of Acuity Brands, Inc. (NYSE: AYI) (the “Company”) announced today the retirement of Dominic J. Pileggi and Ray M. Robinson from the Board at the end of their current terms, effective January 25, 2023. As a result, Mr. Pileggi and Mr. Robinson will not stand for reelection at the Company’s upcoming 2023 Annual Meeting.  “On behalf of the Board, I want to thank Dominic and Ray for their outstanding leadership, distinguished service, and valuable counsel. Their guidance has helped shape the strategy and success of our Company,” said Neil M. Ashe, Chairman, President, and Chief Executive Officer, of Acuity Brands. “We are grateful for their expertise and contributions on our Board throughout their respective tenures. We wish them the very best following...

Continue reading

Theralase ® Closes Private Placement Equity Financing

TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations, used to destroy various cancers, bacteria and viruses, safely and effectively, is pleased to announce that it has closed a non-brokered private placement offering (“Offering”) of units (“Units”). On closing, the Corporation issued an aggregate of 1,000,000 Units at a price of $0.25 per Unit for aggregate gross proceeds of approximately $250,000. Each Unit consisted of one common share of the Company (“Common Share”) and one common share purchase warrant (“Warrant”). Each Warrant entitles the holder to acquire an additional Common...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.